C

CATALENT
D

CTLT

60.950
USD
1.29
(2.16%)
Market Closed
Volume
149,814
EPS
1
Div Yield
-
P/E
-27
Market Cap
11,063,131,167
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.74 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    G
    GMED
    0.030
    (0.04%)
    81.090 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    SYK
    SYK
    6.90
    (1.80%)
    384.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    More
News

Title: CATALENT

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenuesprimarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.